Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT04302220

Myopic Optic Neuropathy in Chinese High Myopia Population

Natural History of Myopic Optic Neuropathy for High Myopia in Chinese Adult Population: a Registry Cohort Study

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
813 (estimated)
Sponsor
Sun Yat-sen University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study intends to establish a registry cohort to enroll patients with high myopia to study the natural course of myopic optic neuropathy in Chinese adult population.

Detailed description

Global prevalence of high myopia brings about markedly increasing of blinding complications as myopic optic neuropathy (MON) and glaucoma. It was estimated that there were 163 million people who have high myopia in 2000, and the population with high myopia would increase to almost one billion (9.8% of the world population) worldwide by 2050. Glaucoma is the leading cause of irreversible blindness worldwide while it is difficult to distinguish glaucoma among MON in high myopia eyes. However, there lack longitudinal study to illustrate the natural course interpreting the distribution and natural history of MON. In view of the above problems, this is a longitudinal registry cohort study to observe the long-term changes of structural and functional parameters of MON in high myopia, and to investigate the natural course and associted risk factors that influence the progression in a Chinese adult population.

Conditions

Timeline

Start date
2019-06-06
Primary completion
2026-06-30
Completion
2026-06-30
First posted
2020-03-10
Last updated
2024-12-09

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04302220. Inclusion in this directory is not an endorsement.

Myopic Optic Neuropathy in Chinese High Myopia Population (NCT04302220) · Clinical Trials Directory